Mutual of America Capital Management LLC Has $418,000 Stock Position in ICU Medical, Inc. $ICUI

Mutual of America Capital Management LLC lowered its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 11.3% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,162 shares of the medical instruments supplier’s stock after selling 404 shares during the quarter. Mutual of America Capital Management LLC’s holdings in ICU Medical were worth $418,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of the stock. Ameriprise Financial Inc. raised its position in ICU Medical by 18.5% in the 1st quarter. Ameriprise Financial Inc. now owns 693,711 shares of the medical instruments supplier’s stock worth $96,326,000 after purchasing an additional 108,493 shares during the last quarter. William Blair Investment Management LLC acquired a new stake in shares of ICU Medical in the 2nd quarter valued at $27,928,000. Invesco Ltd. raised its position in shares of ICU Medical by 80.1% during the first quarter. Invesco Ltd. now owns 203,827 shares of the medical instruments supplier’s stock worth $28,303,000 after acquiring an additional 90,674 shares during the last quarter. Woodline Partners LP raised its position in shares of ICU Medical by 31.6% during the first quarter. Woodline Partners LP now owns 160,910 shares of the medical instruments supplier’s stock worth $22,344,000 after acquiring an additional 38,671 shares during the last quarter. Finally, Victory Capital Management Inc. lifted its stake in shares of ICU Medical by 5.7% during the first quarter. Victory Capital Management Inc. now owns 149,246 shares of the medical instruments supplier’s stock valued at $20,724,000 after acquiring an additional 8,101 shares during the period. 96.10% of the stock is owned by institutional investors.

ICU Medical Stock Down 2.3%

Shares of NASDAQ ICUI opened at $120.11 on Wednesday. ICU Medical, Inc. has a 52-week low of $107.00 and a 52-week high of $196.26. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.17 and a current ratio of 2.44. The stock has a market cap of $2.97 billion, a P/E ratio of -79.02 and a beta of 0.83. The firm has a 50 day moving average price of $124.19 and a 200 day moving average price of $128.93.

ICU Medical (NASDAQ:ICUI) last posted its earnings results on Thursday, August 7th. The medical instruments supplier reported $2.10 earnings per share for the quarter, topping the consensus estimate of $1.44 by $0.66. The company had revenue of $543.57 million for the quarter, compared to analyst estimates of $543.33 million. ICU Medical had a negative net margin of 1.56% and a positive return on equity of 7.24%. The business’s revenue for the quarter was down 8.0% compared to the same quarter last year. During the same period last year, the business posted $1.56 earnings per share. ICU Medical has set its FY 2025 guidance at 6.850-7.15 EPS. Analysts expect that ICU Medical, Inc. will post 4.11 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on ICUI. Wall Street Zen upgraded ICU Medical from a “hold” rating to a “buy” rating in a research report on Friday, September 5th. KeyCorp reduced their target price on shares of ICU Medical from $191.00 to $173.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 21st. Piper Sandler lifted their price target on shares of ICU Medical from $145.00 to $153.00 and gave the stock an “overweight” rating in a research report on Wednesday, September 10th. Raymond James Financial cut their price objective on shares of ICU Medical from $187.00 to $180.00 and set a “strong-buy” rating on the stock in a report on Friday, August 8th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ICU Medical in a research note on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $176.50.

Insider Buying and Selling at ICU Medical

In other ICU Medical news, CEO Vivek Jain purchased 21,929 shares of the stock in a transaction on Thursday, August 14th. The stock was bought at an average cost of $112.84 per share, for a total transaction of $2,474,468.36. Following the completion of the acquisition, the chief executive officer directly owned 130,149 shares of the company’s stock, valued at $14,686,013.16. The trade was a 20.26% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director David C. Greenberg acquired 1,200 shares of the business’s stock in a transaction dated Wednesday, August 27th. The shares were acquired at an average price of $126.42 per share, for a total transaction of $151,704.00. Following the acquisition, the director directly owned 7,960 shares in the company, valued at $1,006,303.20. This represents a 17.75% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Company insiders own 1.50% of the company’s stock.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.